“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries
Background: Horizon scanning aims to systematically identify upcoming health technologies and thus allows policy-makers to be better prepared for the entry of new medicines with possibly high price tags into the national health system. The aim of this study is to survey the existence of national and...
Main Author: | |
---|---|
Format: | Text |
Language: | English |
Published: |
German Medical Science GMS Publishing House
2022
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006311/ https://doi.org/10.3205/000307 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:9006311 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:9006311 2023-05-15T16:52:33+02:00 “Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries Vogler, Sabine 2022-03-31 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006311/ https://doi.org/10.3205/000307 en eng German Medical Science GMS Publishing House http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006311/ http://dx.doi.org/10.3205/000307 Copyright © 2022 Vogler https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . CC-BY Ger Med Sci Article Text 2022 ftpubmed https://doi.org/10.3205/000307 2022-04-24T00:32:42Z Background: Horizon scanning aims to systematically identify upcoming health technologies and thus allows policy-makers to be better prepared for the entry of new medicines with possibly high price tags into the national health system. The aim of this study is to survey the existence of national and cross-national horizon scanning systems for medicines in European countries. Methods: Experts working in public authorities (members of the Pharmaceutical Pricing and Reimbursement Information/PPRI network) in the WHO European region participated in surveys in 2014 and 2019 and informed about the status of horizon scanning in their country (response rate: 14 and 44 countries, respectively). Identified advanced horizon scanning systems as of 2019 were further investigated based on a literature review. Results: In 2019, six countries (Iceland, Italy, the Netherlands, Norway, Sweden, United Kingdom) reported systematic use of horizon scanning for some new medicines, and four countries (Austria, Denmark, France, Ireland) had some horizon scanning activities ongoing. No systematic use of horizon scanning was reported from the remaining 34 countries. The findings of the survey undertaken five years earlier were similar, with even fewer systems in place. A recent development is the establishment of cross-country initiatives of governments that aim, among others, to jointly perform horizon scanning; the International Horizon Scanning Initiative (IHSI) initiated by the Beneluxa collaboration is the most advanced undertaking in this respect. Countries with systematic use tend to have horizon scanning fully integrated in a system for the management of new medicines, and they use horizon scanning outcomes to inform decisions as to whether or not a Health Technology Assessment will be conducted and price negotiations be started. Differences between existing horizon scanning systems mainly concern the timings of scanning and reporting, the sources for the inputs and the accessibility of the findings. Conclusion: There appears to ... Text Iceland PubMed Central (PMC) Norway |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Article |
spellingShingle |
Article Vogler, Sabine “Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries |
topic_facet |
Article |
description |
Background: Horizon scanning aims to systematically identify upcoming health technologies and thus allows policy-makers to be better prepared for the entry of new medicines with possibly high price tags into the national health system. The aim of this study is to survey the existence of national and cross-national horizon scanning systems for medicines in European countries. Methods: Experts working in public authorities (members of the Pharmaceutical Pricing and Reimbursement Information/PPRI network) in the WHO European region participated in surveys in 2014 and 2019 and informed about the status of horizon scanning in their country (response rate: 14 and 44 countries, respectively). Identified advanced horizon scanning systems as of 2019 were further investigated based on a literature review. Results: In 2019, six countries (Iceland, Italy, the Netherlands, Norway, Sweden, United Kingdom) reported systematic use of horizon scanning for some new medicines, and four countries (Austria, Denmark, France, Ireland) had some horizon scanning activities ongoing. No systematic use of horizon scanning was reported from the remaining 34 countries. The findings of the survey undertaken five years earlier were similar, with even fewer systems in place. A recent development is the establishment of cross-country initiatives of governments that aim, among others, to jointly perform horizon scanning; the International Horizon Scanning Initiative (IHSI) initiated by the Beneluxa collaboration is the most advanced undertaking in this respect. Countries with systematic use tend to have horizon scanning fully integrated in a system for the management of new medicines, and they use horizon scanning outcomes to inform decisions as to whether or not a Health Technology Assessment will be conducted and price negotiations be started. Differences between existing horizon scanning systems mainly concern the timings of scanning and reporting, the sources for the inputs and the accessibility of the findings. Conclusion: There appears to ... |
format |
Text |
author |
Vogler, Sabine |
author_facet |
Vogler, Sabine |
author_sort |
Vogler, Sabine |
title |
“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries |
title_short |
“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries |
title_full |
“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries |
title_fullStr |
“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries |
title_full_unstemmed |
“Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries |
title_sort |
“ready for the future?” – status of national and cross-country horizon scanning systems for medicines in european countries |
publisher |
German Medical Science GMS Publishing House |
publishDate |
2022 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006311/ https://doi.org/10.3205/000307 |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
Ger Med Sci |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006311/ http://dx.doi.org/10.3205/000307 |
op_rights |
Copyright © 2022 Vogler https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.3205/000307 |
_version_ |
1766042891782717440 |